Skip to main content
Clinical Trials/NCT02236273
NCT02236273
Completed
Not Applicable

Comparative Effectiveness of Interactive, Health Literacy Promoting Text Messages on HPV Vaccine Completion In Minority Adolescents

Columbia University1 site in 1 country956 target enrollmentDecember 1, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Human Papillomavirus
Sponsor
Columbia University
Enrollment
956
Locations
1
Primary Endpoint
Number of Participants Who Completed HPV Vaccine Series
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

Emerging communication technologies, such as text messaging offer low-cost, scalable opportunities to improve health literacy and promote healthy behaviors, such as vaccination. While the investigators reported the success of text message vaccine reminders, effects were limited by their untailored approach. The trans-theoretical model of behavior change supports tailoring interventions to an individual's stage of decision-making. Human papillomavirus (HPV) is the most prevalent sexually transmitted virus in the U.S. and can lead to genital warts, and cervical, anal and penile cancer. The three-dose vaccine is 90-100% efficacious. Minorities are at greatest risk for such cancers but have low HPV vaccine completion rates. Limited health literacy regarding the vaccine can affect series completion. The investigators will compare the effects of enhancing text message vaccination reminders with interactive, vaccine health literacy-promoting information tailored to vaccine decision making-stage on HPV vaccine series completion. The effects of these messages represent a new paradigm in interactive health communications.

Registry
clinicaltrials.gov
Start Date
December 1, 2014
End Date
December 1, 2017
Last Updated
9 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Melissa Stockwell

Assistant Professor of Pediatrics and Population and Family Health

Columbia University

Eligibility Criteria

Inclusion Criteria

  • Parenting adult of adolescent age 11-17 years
  • Adolescent received 1st dose of HPV at a study site within the last 2 weeks.
  • Eligible parent's cell phone has text message capability

Exclusion Criteria

  • Language other than English or Spanish only
  • Parent already in the study
  • Intends to move away from the New York City area in \<12 months

Outcomes

Primary Outcomes

Number of Participants Who Completed HPV Vaccine Series

Time Frame: 12 months

receipt of 3 doses of HPV vaccine by 12 months after initiation

Secondary Outcomes

  • Time Between 1st and 2nd Dose(12 months)
  • Time Between 1st and 3rd Dose(12 months)

Study Sites (1)

Loading locations...

Similar Trials